BMY: NIH director reportedly being tapped as acting CDC director

The director of the National Institutes of Health (NIH), Jay Bhattacharya, is expected to take on an additional role as ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ 

NIH director reportedly being tapped as acting CDC director 02:14 PM | Bristol-Myers Squibb Company (BMY) | By: Dulan Lokuwithana, SA News Editor Unlimited access to news. Read now >> You may also like: Biggest stock movers Wednesday: PANW, GRMN, MSGS, and more US agencies develop critical minerals price floor to break China dependence, Bloomberg reports Markets AM Need to Know: Microsoft's AI expansion, Meta legal challenge, and more Discover how Seeking Alpha Premium can elevate your strategy FEATURED: Try Seeking Alpha Premium—just $4.95 for your first month** Claim Offer » Manage Alerts   |   Trending News   |   Free Newsletters  Manage Alerts  |  Trending News    Free Investing Newsletters   Download the Seeking Alpha App! Like our Breaking News? Try our other newsletters as well. **Introductory offer for new subscribers only. After your introductory trial, $299 is charged automatically for an annual subscription unless you cancel during your trial. Auto-renews annually. Plus sales tax/VAT where applicable. This email was sent to you because you signed up to receive this Breaking News Alert. If you do not want to receive these real-time alerts, click here to unsubscribe.   Past performance is no guarantee of future results. Any content and tools on the platform are offered for information purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Sent by Seeking Alpha, 244 5th Ave, Suite 2705, New York, NY 10001

CVX: Most and least shorted large-cap energy stocks as of mid-Feb

By mid-February, the S&P 500 energy sector (XLE) moved 22% in the upward direction this year supported by a 13% rise in ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ 

Most and least shorted large-cap energy stocks as of mid-Feb 01:03 PM | (CVX) | By: Khushi Singh, SA News Editor Unlimited access to news. Read now >> You may also like: SA analyst upgrades/downgrades: MSFT, ABNB, SNOW, ENB Dividend picks: 20 large-cap defensive stocks outperforming the market in 2026 Biggest surge of value stocks vs. growth in four years – Jeremy Siegel Discover how Seeking Alpha Premium can elevate your strategy FEATURED: Try Seeking Alpha Premium—just $4.95 for your first month** Claim Offer » Manage Alerts   |   Trending News   |   Free Newsletters  Manage Alerts  |  Trending News    Free Investing Newsletters   Download the Seeking Alpha App! Like our Breaking News? Try our other newsletters as well. **Introductory offer for new subscribers only. After your introductory trial, $299 is charged automatically for an annual subscription unless you cancel during your trial. Auto-renews annually. Plus sales tax/VAT where applicable. This email was sent to you because you signed up to receive this Breaking News Alert. If you do not want to receive these real-time alerts, click here to unsubscribe.   Past performance is no guarantee of future results. Any content and tools on the platform are offered for information purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Sent by Seeking Alpha, 244 5th Ave, Suite 2705, New York, NY 10001

JNJ: J&J to build over $1B cell therapy production site in Pennsylvania

Johnson & Johnson (JNJ) on Wednesday announced plans to construct a cell therapy manufacturing facility in Pennsylvania ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ 

J&J to build over $1B cell therapy production site in Pennsylvania 11:08 AM | Johnson & Johnson (JNJ) | By: Dulan Lokuwithana, SA News Editor Unlimited access to news. Read now >> You may also like: How high can the S&P 500 climb in 2026? Here's what prediction markets are signaling Wall Street slides as investors come back from holiday Costco stuns with its Nike sneaker drop that was popular with Generation X and Z Discover how Seeking Alpha Premium can elevate your strategy FEATURED: Try Seeking Alpha Premium—just $4.95 for your first month** Claim Offer » Manage Alerts   |   Trending News   |   Free Newsletters  Manage Alerts  |  Trending News    Free Investing Newsletters   Download the Seeking Alpha App! Like our Breaking News? Try our other newsletters as well. **Introductory offer for new subscribers only. After your introductory trial, $299 is charged automatically for an annual subscription unless you cancel during your trial. Auto-renews annually. Plus sales tax/VAT where applicable. This email was sent to you because you signed up to receive this Breaking News Alert. If you do not want to receive these real-time alerts, click here to unsubscribe.   Past performance is no guarantee of future results. Any content and tools on the platform are offered for information purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Sent by Seeking Alpha, 244 5th Ave, Suite 2705, New York, NY 10001